Infoscience

Conference paper

MVX-ONCO-1: First in man, Phase I clinical trial combining encapsulation cell technology and irradiated autologous tumor cells for personalized cell-based immunotherapy. Safety, feasibility and clinical outcome results

Fulltext

  • There is no available fulltext. Please contact the lab or the authors.

Related material